Postoperative Communicating Hydrocephalus Following Grade 2/3 Glioma Resection: Incidence, Timing and Risk Factors.
cerebrospinal fluid shunt
glioma
hydrocephalus
postoperative
risk factors
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 Jul 2023
09 Jul 2023
Historique:
received:
05
06
2023
revised:
05
07
2023
accepted:
07
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
In diffusely infiltrating gliomas, the maximum extent of tumor resection is an important predictor of overall survival, irrespective of histological or molecular subtype or tumor grade. For glioblastoma WHO grade 4 (GBM), it has been shown that resection-related events, such as ventricular opening and ventriculitis, increase the risk for development of communicating hydrocephalus (CH) requiring cerebrospinal fluid (CSF) diversion surgery. Risk factors for the development and the incidence of hydrocephalus following resection of other types of infiltrating gliomas are less well established. In this study, we evaluated the incidence and timing of occurrence of different types of hydrocephalus and potential risk factors for the development of CH following resection of grade 2 and 3 gliomas. 346 patients who underwent tumor resection (WHO grade 2: 42.2%; 3: 57.8%) at our department between 2006 and 2019 were analyzed retrospectively. For each patient, age, sex, WHO grade, histological type, IDH mutation and 1p/19q codeletion status, tumor localization, number of resections, rebleeding, ventriculitis, ventricular opening during resection and postoperative CSF leak were determined. Uni- as well as multivariate analyses were performed to identify associations with CH and independent risk factors. 24 out of 346 (6.9%) patients needed CSF diversion surgery (implantation of a ventriculoperitoneal or ventriculoatrial shunt) following resection. Nineteen patients (5.5%) had CH, on median, 44 days after the last resection (interquartile range: 18-89 days). Two patients had obstructive hydrocephalus (OH), and three patients had other CSF circulation disorders. CH was more frequent in grade 3 compared to grade 2 gliomas (8.5 vs. 1.4%). WHO grade 3 (odds ratio (OR) 7.5, Physicians treating brain tumor patients should be aware that postoperative CH requiring CSF shunting occurs not only in GBM but also after resection of lower-grade gliomas, especially in grade 3 tumors. It usually occurs several weeks after resection. Rebleeding and postoperative ventriculitis are independent risk factors.
Sections du résumé
BACKGROUND
BACKGROUND
In diffusely infiltrating gliomas, the maximum extent of tumor resection is an important predictor of overall survival, irrespective of histological or molecular subtype or tumor grade. For glioblastoma WHO grade 4 (GBM), it has been shown that resection-related events, such as ventricular opening and ventriculitis, increase the risk for development of communicating hydrocephalus (CH) requiring cerebrospinal fluid (CSF) diversion surgery. Risk factors for the development and the incidence of hydrocephalus following resection of other types of infiltrating gliomas are less well established. In this study, we evaluated the incidence and timing of occurrence of different types of hydrocephalus and potential risk factors for the development of CH following resection of grade 2 and 3 gliomas.
METHODS
METHODS
346 patients who underwent tumor resection (WHO grade 2: 42.2%; 3: 57.8%) at our department between 2006 and 2019 were analyzed retrospectively. For each patient, age, sex, WHO grade, histological type, IDH mutation and 1p/19q codeletion status, tumor localization, number of resections, rebleeding, ventriculitis, ventricular opening during resection and postoperative CSF leak were determined. Uni- as well as multivariate analyses were performed to identify associations with CH and independent risk factors.
RESULTS
RESULTS
24 out of 346 (6.9%) patients needed CSF diversion surgery (implantation of a ventriculoperitoneal or ventriculoatrial shunt) following resection. Nineteen patients (5.5%) had CH, on median, 44 days after the last resection (interquartile range: 18-89 days). Two patients had obstructive hydrocephalus (OH), and three patients had other CSF circulation disorders. CH was more frequent in grade 3 compared to grade 2 gliomas (8.5 vs. 1.4%). WHO grade 3 (odds ratio (OR) 7.5,
CONCLUSION
CONCLUSIONS
Physicians treating brain tumor patients should be aware that postoperative CH requiring CSF shunting occurs not only in GBM but also after resection of lower-grade gliomas, especially in grade 3 tumors. It usually occurs several weeks after resection. Rebleeding and postoperative ventriculitis are independent risk factors.
Identifiants
pubmed: 37509211
pii: cancers15143548
doi: 10.3390/cancers15143548
pmc: PMC10377207
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Front Oncol. 2022 Sep 12;12:953784
pubmed: 36172160
Zh Vopr Neirokhir Im N N Burdenko. 2018;82(4):81-86
pubmed: 30137041
Clin Neurol Neurosurg. 2003 Dec;106(1):9-15
pubmed: 14643909
Medicine (Baltimore). 2016 Aug;95(31):e4329
pubmed: 27495035
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186
pubmed: 33293629
Semin Pediatr Neurol. 2009 Mar;16(1):9-15
pubmed: 19410151
Neurol Sci. 2002 Dec;23(5):237-41
pubmed: 12522681
J Neurosurg. 2017 Oct;127(4):807-811
pubmed: 27935360
J Neurosurg. 1981 Aug;55(2):174-82
pubmed: 7252539
Ann Oncol. 2017 Aug 01;28(8):1942-1948
pubmed: 28475680
J Neurosurg Sci. 2020 Apr;64(2):181-189
pubmed: 30942051
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
World Neurosurg. 2011 Dec;76(6):572-9
pubmed: 22251506
N Engl J Med. 2016 Apr 7;374(14):1344-55
pubmed: 27050206
Clin Microbiol Infect. 2017 Sep;23(9):621-628
pubmed: 28529027
Front Oncol. 2022 Feb 09;12:796105
pubmed: 35223477
Neurosurgery. 2011 Oct;69(4):864-8; discussion 868-9
pubmed: 21900810
Clin Neurol Neurosurg. 2014 May;120:27-31
pubmed: 24731571
Nat Rev Clin Oncol. 2009 Nov;6(11):648-57
pubmed: 19806145
Neuroradiology. 1990;32(2):146-50
pubmed: 2398940
Acta Neurochir (Wien). 2008 Jan;150(1):41-6; discussion 46-7
pubmed: 18180865
J Korean Neurosurg Soc. 2017 Nov;60(6):730-737
pubmed: 29142634
Neurosurgery. 2003 Apr;52(4):763-9; discussion 769-71
pubmed: 12657171
Acta Neurochir (Wien). 2017 Mar;159(3):403-418
pubmed: 28093610
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
J Neurosurg. 2011 Dec;115(6):1126-30
pubmed: 21905801
J Neurooncol. 2020 May;148(1):187-198
pubmed: 32342331
Neurosurgery. 2017 Mar 1;80(3):421-430
pubmed: 27218235
Lancet Oncol. 2021 Jun;22(6):813-823
pubmed: 34000245
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
JAMA. 2012 Nov 14;308(18):1881-8
pubmed: 23099483
J Neurosurg Pediatr. 2014 Jan;13(1):13-20
pubmed: 24180680